Pseudo  ||| S:0 E:7 ||| JJ
tumours  ||| S:7 E:15 ||| NN
in  ||| S:15 E:18 ||| IN
haemophilia  ||| S:18 E:30 ||| JJ
patients  ||| S:30 E:39 ||| NNS
Pseudo  ||| S:39 E:46 ||| JJ
tumours  ||| S:46 E:54 ||| NNS
are  ||| S:54 E:58 ||| VBP
amongst  ||| S:58 E:66 ||| IN
the  ||| S:66 E:70 ||| DT
rare  ||| S:70 E:75 ||| JJ
yet  ||| S:75 E:79 ||| RB
pathognomonic  ||| S:79 E:93 ||| JJ
complications  ||| S:93 E:107 ||| NNS
of  ||| S:107 E:110 ||| IN
haemophilia ||| S:110 E:121 ||| NN
.  ||| S:121 E:123 ||| .
They  ||| S:123 E:128 ||| PRP
are  ||| S:128 E:132 ||| VBP
old ||| S:132 E:135 ||| JJ
,  ||| S:135 E:137 ||| ,
encapsulated  ||| S:137 E:150 ||| JJ
haematomas  ||| S:150 E:161 ||| NN
which  ||| S:161 E:167 ||| WDT
due  ||| S:167 E:171 ||| JJ
to  ||| S:171 E:174 ||| TO
their  ||| S:174 E:180 ||| PRP$
sometimes  ||| S:180 E:190 ||| RB
enormous  ||| S:190 E:199 ||| JJ
size  ||| S:199 E:204 ||| NN
can  ||| S:204 E:208 ||| MD
cause  ||| S:208 E:214 ||| VB
massive  ||| S:214 E:222 ||| JJ
complaints ||| S:222 E:232 ||| NNS
.  ||| S:232 E:234 ||| .
These  ||| S:234 E:240 ||| DT
haematomas  ||| S:240 E:251 ||| NNS
are  ||| S:251 E:255 ||| VBP
surrounded  ||| S:255 E:266 ||| VBN
by  ||| S:266 E:269 ||| IN
a  ||| S:269 E:271 ||| DT
thick  ||| S:271 E:277 ||| JJ
fibrous  ||| S:277 E:285 ||| JJ
capsule ||| S:285 E:292 ||| NN
.  ||| S:292 E:294 ||| .
They  ||| S:294 E:299 ||| PRP
are  ||| S:299 E:303 ||| VBP
attributed  ||| S:303 E:314 ||| VBN
to  ||| S:314 E:317 ||| TO
persistent  ||| S:317 E:328 ||| JJ
bleedings ||| S:328 E:337 ||| NN
.  ||| S:337 E:339 ||| .
The  ||| S:339 E:343 ||| DT
pathophysiology  ||| S:343 E:359 ||| NN
of  ||| S:359 E:362 ||| IN
pseudo  ||| S:362 E:369 ||| JJ
tumors  ||| S:369 E:376 ||| NN
is  ||| S:376 E:379 ||| VBZ
not  ||| S:379 E:383 ||| RB
conclusively  ||| S:383 E:396 ||| RB
established  ||| S:396 E:408 ||| VBN
yet ||| S:408 E:411 ||| RB
.  ||| S:411 E:413 ||| .
Some  ||| S:413 E:418 ||| DT
believe  ||| S:418 E:426 ||| VBP
that  ||| S:426 E:431 ||| IN
they  ||| S:431 E:436 ||| PRP
originate  ||| S:436 E:446 ||| VBD
from  ||| S:446 E:451 ||| IN
bone  ||| S:451 E:456 ||| NN
material  ||| S:456 E:465 ||| NN
or  ||| S:465 E:468 ||| CC
the  ||| S:468 E:472 ||| DT
periosteum ||| S:472 E:482 ||| NN
,  ||| S:482 E:484 ||| ,
while  ||| S:484 E:490 ||| IN
others  ||| S:490 E:497 ||| NNS
suggest  ||| S:497 E:505 ||| VBP
their  ||| S:505 E:511 ||| PRP$
development  ||| S:511 E:523 ||| NN
from  ||| S:523 E:528 ||| IN
soft  ||| S:528 E:533 ||| JJ
tissue ||| S:533 E:539 ||| NN
.  ||| S:539 E:541 ||| .
They  ||| S:541 E:546 ||| PRP
spread  ||| S:546 E:553 ||| VBD
aggressively ||| S:553 E:565 ||| RB
,  ||| S:565 E:567 ||| ,
displace  ||| S:567 E:576 ||| VBG
the  ||| S:576 E:580 ||| DT
surrounding  ||| S:580 E:592 ||| JJ
tissue ||| S:592 E:598 ||| NN
,  ||| S:598 E:600 ||| ,
and  ||| S:600 E:604 ||| CC
cause  ||| S:604 E:610 ||| VB
secondary  ||| S:610 E:620 ||| JJ
periosteal  ||| S:620 E:631 ||| JJ
erosion  ||| S:631 E:639 ||| NN
of  ||| S:639 E:642 ||| IN
the  ||| S:642 E:646 ||| DT
bone ||| S:646 E:650 ||| NN
.  ||| S:650 E:652 ||| .
This  ||| S:652 E:657 ||| DT
results  ||| S:657 E:665 ||| NNS
in  ||| S:665 E:668 ||| IN
bone  ||| S:668 E:673 ||| NN
resorption  ||| S:673 E:684 ||| NNS
and  ||| S:684 E:688 ||| CC
destruction  ||| S:688 E:700 ||| NN
of  ||| S:700 E:703 ||| IN
surrounding  ||| S:703 E:715 ||| VBG
muscular  ||| S:715 E:724 ||| NNS
and  ||| S:724 E:728 ||| CC
soft  ||| S:728 E:733 ||| JJ
tissue ||| S:733 E:739 ||| NN
.  ||| S:739 E:741 ||| .
Pseudo  ||| S:741 E:748 ||| JJ
tumours  ||| S:748 E:756 ||| NNS
develop  ||| S:756 E:764 ||| VBP
slowly  ||| S:764 E:771 ||| RB
over  ||| S:771 E:776 ||| IN
many  ||| S:776 E:781 ||| JJ
years ||| S:781 E:786 ||| NNS
.  ||| S:786 E:788 ||| .
They  ||| S:788 E:793 ||| PRP
occur  ||| S:793 E:799 ||| VBP
primarily  ||| S:799 E:809 ||| RB
in  ||| S:809 E:812 ||| IN
adults  ||| S:812 E:819 ||| NNS
and  ||| S:819 E:823 ||| CC
are  ||| S:823 E:827 ||| VBP
largely  ||| S:827 E:835 ||| RB
unresponsive  ||| S:835 E:848 ||| VBN
to  ||| S:848 E:851 ||| TO
conservative  ||| S:851 E:864 ||| JJ
treatment ||| S:864 E:873 ||| NN
.  ||| S:873 E:875 ||| .
A  ||| S:875 E:877 ||| DT
48-year-old  ||| S:877 E:889 ||| JJ
man  ||| S:889 E:893 ||| NN
with  ||| S:893 E:898 ||| IN
moderate  ||| S:898 E:907 ||| JJ
hemophiliaA  ||| S:907 E:919 ||| NN
( ||| S:919 E:920 ||| -LRB-
FVIII ||| S:920 E:925 ||| NNP
: ||| S:925 E:926 ||| :
C  ||| S:926 E:928 ||| $
2 ||| S:928 E:929 ||| CD
% ||| S:929 E:930 ||| NN
)  ||| S:930 E:932 ||| -RRB-
and  ||| S:932 E:936 ||| CC
no  ||| S:936 E:939 ||| DT
FVIII  ||| S:939 E:945 ||| NNP
inhibitor ||| S:945 E:954 ||| NN
.  ||| S:954 E:956 ||| .
Due  ||| S:956 E:960 ||| JJ
to  ||| S:960 E:963 ||| TO
recurrent  ||| S:963 E:973 ||| VB
bleeding  ||| S:973 E:982 ||| VBG
into  ||| S:982 E:987 ||| IN
the  ||| S:987 E:991 ||| DT
muscle  ||| S:991 E:998 ||| NN
of  ||| S:998 E:1001 ||| IN
the  ||| S:1001 E:1005 ||| DT
right  ||| S:1005 E:1011 ||| JJ
thigh  ||| S:1011 E:1017 ||| JJ
diagnosis  ||| S:1017 E:1027 ||| NN
of  ||| S:1027 E:1030 ||| IN
two  ||| S:1030 E:1034 ||| CD
pseudo  ||| S:1034 E:1041 ||| CD
tumours  ||| S:1041 E:1049 ||| NNS
( ||| S:1049 E:1050 ||| -LRB-
psoas ||| S:1050 E:1055 ||| UH
,  ||| S:1055 E:1057 ||| ,
adductor  ||| S:1057 E:1066 ||| JJ
magnus ||| S:1066 E:1072 ||| NN
) ||| S:1072 E:1073 ||| -RRB-
.  ||| S:1073 E:1075 ||| .
In  ||| S:1075 E:1078 ||| IN
2004  ||| S:1078 E:1083 ||| CD
tumour  ||| S:1083 E:1090 ||| JJ
extirpation  ||| S:1090 E:1102 ||| NN
with  ||| S:1102 E:1107 ||| IN
subsequent  ||| S:1107 E:1118 ||| JJ
relapse ||| S:1118 E:1125 ||| NN
;  ||| S:1125 E:1127 ||| :
because  ||| S:1127 E:1135 ||| IN
of  ||| S:1135 E:1138 ||| IN
high  ||| S:1138 E:1143 ||| JJ
local  ||| S:1143 E:1149 ||| JJ
bleeding  ||| S:1149 E:1158 ||| NN
tendency  ||| S:1158 E:1167 ||| NN
( ||| S:1167 E:1168 ||| -LRB-
despite  ||| S:1168 E:1176 ||| IN
permanent  ||| S:1176 E:1186 ||| JJ
prophylaxis  ||| S:1186 E:1198 ||| NN
with  ||| S:1198 E:1203 ||| IN
FVIII  ||| S:1203 E:1209 ||| NNP
concentrate  ||| S:1209 E:1221 ||| NN
and  ||| S:1221 E:1225 ||| CC
adjusted  ||| S:1225 E:1234 ||| JJ
lifestyle ||| S:1234 E:1243 ||| NN
)  ||| S:1243 E:1245 ||| -RRB-
surgical  ||| S:1245 E:1254 ||| JJ
revision  ||| S:1254 E:1263 ||| NN
in  ||| S:1263 E:1266 ||| IN
02 ||| S:1266 E:1268 ||| CD
/ ||| S:1268 E:1269 ||| CD
2008 ||| S:1269 E:1273 ||| CD
.  ||| S:1273 E:1275 ||| .
Postoperatively ||| S:1275 E:1290 ||| NNP
,  ||| S:1290 E:1292 ||| ,
no  ||| S:1292 E:1295 ||| DT
recurrent  ||| S:1295 E:1305 ||| JJ
bleeding ||| S:1305 E:1313 ||| NN
;  ||| S:1313 E:1315 ||| :
the  ||| S:1315 E:1319 ||| DT
patient  ||| S:1319 E:1327 ||| NN
is  ||| S:1327 E:1330 ||| VBZ
fully  ||| S:1330 E:1336 ||| RB
fit  ||| S:1336 E:1340 ||| VB
for  ||| S:1340 E:1344 ||| IN
work  ||| S:1344 E:1349 ||| NN
three  ||| S:1349 E:1355 ||| CD
months  ||| S:1355 E:1362 ||| NNS
later ||| S:1362 E:1367 ||| RB
.  ||| S:1367 E:1369 ||| .
In  ||| S:1369 E:1372 ||| IN
order  ||| S:1372 E:1378 ||| NN
to  ||| S:1378 E:1381 ||| TO
reduce  ||| S:1381 E:1388 ||| VB
the  ||| S:1388 E:1392 ||| DT
complication  ||| S:1392 E:1405 ||| JJ
rate  ||| S:1405 E:1410 ||| NN
when  ||| S:1410 E:1415 ||| WRB
a  ||| S:1415 E:1417 ||| DT
pseudo  ||| S:1417 E:1424 ||| JJ
tumor  ||| S:1424 E:1430 ||| NN
is  ||| S:1430 E:1433 ||| VBZ
suspected ||| S:1433 E:1442 ||| VBN
,  ||| S:1442 E:1444 ||| ,
patients  ||| S:1444 E:1453 ||| NNS
should  ||| S:1453 E:1460 ||| MD
be  ||| S:1460 E:1463 ||| VB
treated  ||| S:1463 E:1471 ||| VBN
in  ||| S:1471 E:1474 ||| IN
a  ||| S:1474 E:1476 ||| DT
specially  ||| S:1476 E:1486 ||| RB
equipped  ||| S:1486 E:1495 ||| VBN
interdisciplinary  ||| S:1495 E:1513 ||| JJ
center  ||| S:1513 E:1520 ||| NN
with  ||| S:1520 E:1525 ||| IN
adequately  ||| S:1525 E:1536 ||| RB
trained  ||| S:1536 E:1544 ||| VBN
and  ||| S:1544 E:1548 ||| CC
experienced  ||| S:1548 E:1560 ||| JJ
surgeons  ||| S:1560 E:1569 ||| NN
and  ||| S:1569 E:1573 ||| CC
haemostaseologists ||| S:1573 E:1591 ||| NN
.  ||| S:1591 E:1593 ||| .
